Related references
Note: Only part of the references are listed.Analysis of clinical manifestations and treatment in 26 children with fibrodysplasia ossificans progressiva in China
Jun-Mei Zhang et al.
WORLD JOURNAL OF PEDIATRICS (2020)
Inflammatory Role of TLR-MyD88 Signaling in Multiple Sclerosis
Chao Zheng et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2020)
Urinary biomarkers for lupus nephritis: the role of the vascular cell adhesion molecule-1
A. A. Gasparin et al.
LUPUS (2019)
A cell-penetrating peptide blocks Toll-like receptor-mediated downstream signaling and ameliorates autoimmune and inflammatory diseases in mice
Hyuk-Kwon Kwon et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2019)
TLR7 Protein Expression in Mild and Severe Lupus-Prone Models Is Regulated in a Leukocyte, Genetic, and IRAK4 Dependent Manner
Teja Celhar et al.
FRONTIERS IN IMMUNOLOGY (2019)
New therapeutic strategies in systemic lupus erythematosus management
Mariele Gatto et al.
NATURE REVIEWS RHEUMATOLOGY (2019)
Polymorphisms of MFGE8 are associated with susceptibility and clinical manifestations through gene expression modulation in Koreans with systemic lupus erythematosus
Wook-Young Baek et al.
SCIENTIFIC REPORTS (2019)
Interleukin-1 receptor-associated kinase 4 (IRAK4) plays a dual role in myddosome formation and Toll-like receptor signaling
Dominic De Nardo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
The Transcription Factor Ets1 Suppresses T Follicular Helper Type 2 Cell Differentiation to Halt the Onset of Systemic Lupus Erythematosus
Chan Johng Kim et al.
IMMUNITY (2018)
Pathogenesis of Human Systemic Lupus Erythematosus: A Cellular Perspective
Vaishali R. Moulton et al.
TRENDS IN MOLECULAR MEDICINE (2017)
Clinical Outcomes Observed among Biopsy Proven Lupus Nephritis Patients Treated with Mycophenolate Mofetil as First-line Therapy
Holm Timlin et al.
CUREUS JOURNAL OF MEDICAL SCIENCE (2017)
Clinical features and antinuclear antibodies profile among adults with systemic lupus erythematosus and lupus nephritis: a cross-sectional study
Nashwa Ahmed et al.
PAN AFRICAN MEDICAL JOURNAL (2017)
The Role of the Transcription Factor Ets1 in Lupus and Other Autoimmune Diseases
Lee Ann Garrett-Sinha et al.
CRITICAL REVIEWS IN IMMUNOLOGY (2016)
Kidney Expression of Toll Like Receptors in Lupus Nephritis: Quantification and Clinicopathological Correlations
Fabrizio Conti et al.
MEDIATORS OF INFLAMMATION (2016)
Genetic Factors in Systemic Lupus Erythematosus: Contribution to Disease Phenotype
Fulvia Ceccarelli et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2015)
Mechanisms of kidney injury in lupus nephritis - the role of anti-dsDNA antibodies
Susan Yung et al.
FRONTIERS IN IMMUNOLOGY (2015)
Systemic lupus erythematosus
Larissa Lisnevskaia et al.
LANCET (2014)
Toll-like receptor signaling pathways
Takumi Kawasaki et al.
FRONTIERS IN IMMUNOLOGY (2014)
The history of Toll-like receptors - redefining innate immunity
Luke A. J. O'Neill et al.
NATURE REVIEWS IMMUNOLOGY (2013)
Nucleic acid sensing Toll-like receptors in autoimmunity
Sarah E. Ewald et al.
CURRENT OPINION IN IMMUNOLOGY (2011)
Inflammatory Cytokines in Systemic Lupus Erythematosus
Kim Ohl et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2011)
MECHANISMS OF DISEASE Systemic Lupus Erythematosus
George C. Tsokos
NEW ENGLAND JOURNAL OF MEDICINE (2011)
TLR-dependent T cell activation in autoimmunity
Kingston H. G. Mills
NATURE REVIEWS IMMUNOLOGY (2011)
Targeting Toll-like receptors: emerging therapeutics?
Elizabeth J. Hennessy et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Recent insights into the genetic basis of systemic lupus erythematosus
K. L. Moser et al.
GENES AND IMMUNITY (2009)
Protein Kinase D1 Is Essential for MyD88-Dependent TLR Signaling Pathway
Jeoung-Eun Park et al.
JOURNAL OF IMMUNOLOGY (2009)
Anti-DNA antibodies in the pathogenesis of lupus nephritis - The emerging mechanisms
Susan Yung et al.
AUTOIMMUNITY REVIEWS (2008)
Mechanisms of disease: Systemic lupus erythematosus
Anisur Rahman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Recognition of microorganisms and activation of the immune response
Ruslan Medzhitov
NATURE (2007)
Toll-like receptors and type I interferons
Satoshi Uematsu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Systemic lupus erythematosus
David P. D'Cruz et al.
LANCET (2007)
DAMPs, PAMPs and alarmins: all we need to know about danger
Marco E. Bianchi
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
Autoantibody profiling to identify individuals at risk for systemic lupus erythematosus
Amy E. Wandstrat et al.
JOURNAL OF AUTOIMMUNITY (2006)
Toll-like receptors in systemic autoimmune disease
Ann Marshak-Rothstein
NATURE REVIEWS IMMUNOLOGY (2006)
Toll-like receptor 7-dependent loss of B cell tolerance in pathogenic autoantibody knockin mice
Robert Berland et al.
IMMUNITY (2006)
Genomic view of systemic autoimmunity in MRLlpr mice
J Liu et al.
GENES AND IMMUNITY (2006)
Pathogen recognition and innate immunity
S Akira et al.
CELL (2006)
Toll-like receptor-7 modulates immune complex glomerulonephritis
Rahul D. Pawar et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Interleukin-1 receptor-associated kinase-1 plays an essential role for Toll-like receptor (TLR)7- and TLR9-mediated interferon-α induction
S Uematsu et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Toll-like receptor downstream signaling
T Kawai et al.
ARTHRITIS RESEARCH & THERAPY (2005)
Interferon-α induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6
T Kawai et al.
NATURE IMMUNOLOGY (2004)
Development of autoantibodies before the clinical onset of systemic lupus erythematosus
MR Arbuckle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus
EC Baechler et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Distinct molecular mechanism for initiating TRAF6 signalling
H Ye et al.
NATURE (2002)
Complement and systemic lupus erythematosus
Mark J. Walport
ARTHRITIS RESEARCH & THERAPY (2002)